Sonomaceuticals partnered with PIPA to unlock the full health potential of WellVine, an upcycled ingredient derived from Chardonnay marc. The goal was to rapidly identify health-promoting molecules and scientifically grounded ingredient pairings that could expand product concepts and speed commercialization.
A New Level of Biological Insight
Using PIPA’s LEAP platform, the team integrated biomedical literature, proprietary datasets, and AI prediction to surface known and novel health benefits linked to WellVine. The analysis also evaluated synergistic ingredient combinations to maximize efficacy across multiple consumer health areas.
The collaboration converted complex molecular data into product-ready insights, enabling faster by-product valorization and supporting innovation across multiple functional nutrition categories.
Hundreds of candidate ingredients identified with scientific evidence supporting pairing with WellVine
5× faster discovery cycles, reducing timelines from the industry norm of 4 to 6 years to months
6× faster R&D screening, enabling data-driven, cost-efficient lab testing and product design
A perspective from from the Sonomaceuticals/WellVine team
“At Sonomaceuticals, we’re passionate about pushing the boundaries of what’s possible in the food industry. Our commitment to innovation, sustainability, and consumer health drives everything we do, and we’re thrilled to share our progress with the world. Our exploration of the benefit space of Chardonnay Marc through PIPA’s AI has been a game-changer, allowing us to discover evidence and insights at an unprecedented speed. We’re excited to continue our research and development efforts and create products that are not only good for us and the planet, but also taste amazing.”
Scott Forsberg, Chief Operating Officer Sonomaceuticals
Technologies
Let’s advance food innovation together
Move innovation forward more quickly and safely by leveraging our AI platforms and expert talent.
